BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30211828)

  • 1. NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients.
    Calabrese DR; Chong T; Wang A; Singer JP; Gottschall M; Hays SR; Golden JA; Kukreja J; Lanier LL; Tang Q; Greenland JR
    Transplantation; 2019 Mar; 103(3):493-501. PubMed ID: 30211828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of Cytomegalovirus-induced NKG2C+ Natural Killer Cells in the Lung Allograft.
    Harpur CM; Stankovic S; Kanagarajah A; Widjaja JML; Levvey BJ; Cristiano Y; Snell GI; Brooks AG; Westall GP; Sullivan LC
    Transplantation; 2019 Aug; 103(8):1689-1699. PubMed ID: 30461721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.
    Redondo-Pachón D; Crespo M; Yélamos J; Muntasell A; Pérez-Sáez MJ; Pérez-Fernández S; Vila J; Vilches C; Pascual J; López-Botet M
    J Immunol; 2017 Jan; 198(1):94-101. PubMed ID: 27913630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.
    Muñoz-Cobo B; Giménez E; Solano C; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Navarro D
    J Med Virol; 2014 May; 86(5):806-11. PubMed ID: 24105728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
    Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D
    J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients.
    Ishiyama K; Arakawa-Hoyt J; Aguilar OA; Damm I; Towfighi P; Sigdel T; Tamaki S; Babdor J; Spitzer MH; Reed EF; Sarwal MM; Lanier LL;
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35181606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Evolution of the Adaptive NKG2C
    Ataya M; Redondo-Pachón D; Llinàs-Mallol L; Yélamos J; Alari-Pahissa E; Pérez-Sáez MJ; Altadill M; Raïch-Regué D; Vilches C; Pascual J; Crespo M; López-Botet M
    J Immunol; 2021 Oct; 207(7):1882-1890. PubMed ID: 34470855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of IFNγ-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation.
    Jin F; Lin H; Gao S; Wang H; Yan H; Guo J; Hu Z; Jin C; Wang Y; Wang Z; Zhao Y; Liu Y; Zheng X; Tan Y; Li W; Dai Y; Yang Y
    Oncotarget; 2017 Jan; 8(1):51-63. PubMed ID: 27980216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
    Foley B; Cooley S; Verneris MR; Pitt M; Curtsinger J; Luo X; Lopez-Vergès S; Lanier LL; Weisdorf D; Miller JS
    Blood; 2012 Mar; 119(11):2665-74. PubMed ID: 22180440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.
    Foley B; Cooley S; Verneris MR; Curtsinger J; Luo X; Waller EK; Anasetti C; Weisdorf D; Miller JS
    J Immunol; 2012 Nov; 189(10):5082-8. PubMed ID: 23077239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Signatures of Natural Killer Cells in CMV-Associated Anterior Uveitis, A New Type of CMV-Induced Disease in Immunocompetent Individuals.
    Yawata N; Shirane M; Woon K; Lim X; Tanaka H; Kawano YI; Yawata M; Chee SP; Siak J; Sonoda KH
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust 8-color flow cytometry panel reveals enhanced effector function of NKG2C
    Nerreter T; Zeiß S; Herrmann T; Einsele H; Seggewiss-Bernhardt R
    Immunobiology; 2017 May; 222(5):719-725. PubMed ID: 28139257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.
    Martínez-Rodríguez JE; Munné-Collado J; Rasal R; Cuadrado E; Roig L; Ois A; Muntasell A; Baro T; Alameda F; Roquer J; López-Botet M
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2653-9. PubMed ID: 23968979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus.
    Ariyanto IA; Estiasari R; Edwar L; Makwana N; Lee S; Price P
    Immunol Invest; 2019 May; 48(4):345-354. PubMed ID: 30422022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
    Lopez-Vergès S; Milush JM; Schwartz BS; Pando MJ; Jarjoura J; York VA; Houchins JP; Miller S; Kang SM; Norris PJ; Nixon DF; Lanier LL
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14725-32. PubMed ID: 21825173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells.
    Djaoud Z; Riou R; Gavlovsky PJ; Mehlal S; Bressollette C; Gérard N; Gagne K; Charreau B; Retière C
    J Innate Immun; 2016; 8(4):374-85. PubMed ID: 27116381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation.
    Cao K; Marin D; Sekine T; Rondon G; Zhao W; Smith NT; Daher M; Wang Q; Li L; Saliba RM; Pingali R; Popat U; Hosing C; Olson A; Oran B; Basar R; Mehta RS; Champlin R; Shpall EJ; Rezvani K
    Front Immunol; 2018; 9():2444. PubMed ID: 30405633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation.
    Yu XX; Shang QN; Liu XF; He M; Pei XY; Mo XD; Lv M; Han TT; Huo MR; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Zhao XY; Huang XJ
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34990406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.
    Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M
    J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
    Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
    AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.